Endo (NDOI) FCF Yield % : -36.60 (As of Apr. 01, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Endo FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Endo's Trailing 12-Month Free Cash Flow is $-669 Mil, and Market Cap is $1,829 Mil. Therefore, Endo's FCF Yield % for today is -36.60%.

The historical rank and industry rank for Endo's FCF Yield % or its related term are showing as below:

NDOI' s FCF Yield % Range Over the Past 10 Years
Min: -36.98 Med: -31.19 Max: -28.26
Current: -36.6

During the past 3 years, the highest FCF Yield % of Endo was -28.26%. The lowest was -36.98%. And the median was -31.19%.

NDOI's FCF Yield % is ranked worse than
91.43% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 0.1 vs NDOI: -36.60

Endo's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Endo FCF Yield % Historical Data

The historical data trend for Endo's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo FCF Yield % Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

FCF Yield %

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Endo's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Endo's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endo's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Endo's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Endo FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Endo's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	0	/	1867.1695
	=	0.00%

Endo's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	1867.1695
	=	0.00%

Endo FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Endo FCF Yield % Related Terms

Thank you for viewing the detailed overview of Endo's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.